Article

(2022) Berberine as a natural modulator of inflammatory signaling pathways in the immune system: Focus on NF-kappaB, JAK/STAT, and MAPK signaling pathways. Phytotherapy research : PTR. ISSN 1099-1573 (Electronic) 0951-418X (Linking)

(2022) Berberine as a natural modulator of inflammatory signaling pathways in the immune system: Focus on NF-κB, JAK/STAT, and MAPK signaling pathways. Phytotherapy Research. pp. 1216-1230. ISSN 0951418X (ISSN)

(2021) Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1. Journal for Immunotherapy of Cancer. p. 9.

(2020) Modulatory effects of curcumin on the atherogenic activities of inflammatory monocytes: Evidence from in vitro and animal models of human atherosclerosis. Biofactors. pp. 341-355. ISSN 0951-6433

Book Section

(2020) Promising Anti-atherosclerotic Effect of Berberine: Evidence from In Vitro, In Vivo, and Clinical Studies. In: Reviews of Physiology, Biochemistry and Pharmacology, Vol 178. Reviews of Physiology Biochemistry and Pharmacology, 178 . Springer International Publishing Ag, Cham, pp. 83-110. ISBN 978-3-030-61507-9; 978-3-030-61506-2